Skip to main content
Erschienen in: Acta Neurologica Belgica 1/2018

03.10.2017 | Original Article

Vitamin D and disability in relapsing–remitting multiple sclerosis in patients with a Mexican background

verfasst von: Yamel Rito, Jesus Flores, Angeles Fernández-Aguilar, Carmen Escalante-Membrillo, Miguel A. Barboza, Lilyana Amezcua, Teresa Corona

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Previous studies of multiple sclerosis (MS) patients have reported an inverse correlation between disability, the number of relapses and vitamin D levels in mostly white patients. It is unclear if this relationship has the same behavior in individuals with Hispanic backgrounds. To determine the relationship between vitamin D serum levels and disability in a sample of Hispanics of a Mexican background with relapsing–remitting multiple sclerosis (RRMS). A cross-sectional study was conducted on 50 RRMS individuals of Mexican background. The Expanded Disability Status Scale (EDSS) score, progression index (PI) and annual relapse rate (ARR) were recorded for each patient. Vitamin D levels were assessed during the summer. Pearson’s test was used to evaluate the relationship between vitamin D and EDSS, PI, ARR, and duration of disease evolution. Most patients were females (n = 29, 58%). The mean vitamin D level was 22.3 (± 6.4) ng/ml; the mean EDSS score was 2.2 (± 0.7), ARR 1.3 (± 0.5) and PI1.08 (± 0.6). No correlation was found between vitamin D levels and EDSS scores, ARR, PI or duration of disease. Moderate negative association between vitamin D levels and EDSS was found just in females (<0.0001). No correlation between vitamin D levels and disability was found in this sample of RRMS Mexicans. Longitudinal studies are needed to better understand the impact of Vitamin D in disability and multiple time points.
Literatur
1.
Zurück zum Zitat Kamm CP, Uitdehaag BM, Polman CH (2014) Multiple sclerosis: current knowledge and future outlook. Eur Neurol 72:132–141CrossRefPubMed Kamm CP, Uitdehaag BM, Polman CH (2014) Multiple sclerosis: current knowledge and future outlook. Eur Neurol 72:132–141CrossRefPubMed
2.
Zurück zum Zitat Kantarci OH, Weinshenker BG (2005) Natural history of multiple sclerosis. Neurol Clin 23:17–38CrossRefPubMed Kantarci OH, Weinshenker BG (2005) Natural history of multiple sclerosis. Neurol Clin 23:17–38CrossRefPubMed
3.
Zurück zum Zitat Corona T, Rodrigues JL, Otero E, Stopp L (1996) Multiple sclerosis in Mexico: hospital cases at the National Institute of Neurology and Neurosurgery, Mexico City. Neurologia 11:170–173 (Barcelona, Spain) PubMed Corona T, Rodrigues JL, Otero E, Stopp L (1996) Multiple sclerosis in Mexico: hospital cases at the National Institute of Neurology and Neurosurgery, Mexico City. Neurologia 11:170–173 (Barcelona, Spain) PubMed
4.
Zurück zum Zitat Aguirre-Cruz L, Flores-Rivera J, De La Cruz-Aguilera DL, Rangel-López E, Corona T (2011) Multiple sclerosis in Caucasians and Latino Americans. Autoimmunity 44:571–575CrossRefPubMed Aguirre-Cruz L, Flores-Rivera J, De La Cruz-Aguilera DL, Rangel-López E, Corona T (2011) Multiple sclerosis in Caucasians and Latino Americans. Autoimmunity 44:571–575CrossRefPubMed
5.
Zurück zum Zitat Melcon MO, Melcon CM, Bartoloni L et al (2013) Towards establishing MS prevalence in Latin America and the Caribbean. Mult Scler 19:145–152CrossRefPubMed Melcon MO, Melcon CM, Bartoloni L et al (2013) Towards establishing MS prevalence in Latin America and the Caribbean. Mult Scler 19:145–152CrossRefPubMed
6.
7.
Zurück zum Zitat Mandia D, Ferraro OE, Nosari G, Montomoli C, Zardini E, Bergamaschi R (2014) Environmental factors and multiple sclerosis severity: a descriptive study. Int J Environ Res Public Health 11:6417–6432CrossRefPubMedPubMedCentral Mandia D, Ferraro OE, Nosari G, Montomoli C, Zardini E, Bergamaschi R (2014) Environmental factors and multiple sclerosis severity: a descriptive study. Int J Environ Res Public Health 11:6417–6432CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Pierrot-Deseilligny C, Souberbielle J-C (2010) Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain 133:1869–1888CrossRefPubMed Pierrot-Deseilligny C, Souberbielle J-C (2010) Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain 133:1869–1888CrossRefPubMed
10.
Zurück zum Zitat Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y (2016) Vitamin D and autoimmunity. Scand J Rheumatol 45:439–447CrossRefPubMed Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y (2016) Vitamin D and autoimmunity. Scand J Rheumatol 45:439–447CrossRefPubMed
12.
Zurück zum Zitat Correale J, Ysrraelit MC, Gaitn MI (2009) Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132:1146–1160CrossRefPubMed Correale J, Ysrraelit MC, Gaitn MI (2009) Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132:1146–1160CrossRefPubMed
14.
Zurück zum Zitat Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832–2838CrossRefPubMed Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296:2832–2838CrossRefPubMed
15.
Zurück zum Zitat Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11:266–271CrossRefPubMed Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A (2005) 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11:266–271CrossRefPubMed
16.
Zurück zum Zitat Gelfand JM, Cree BAC, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ (2011) Vitamin D in African Americans with multiple sclerosis. Neurology 76:1824–1830CrossRefPubMedPubMedCentral Gelfand JM, Cree BAC, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ (2011) Vitamin D in African Americans with multiple sclerosis. Neurology 76:1824–1830CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Amezcua L, Chung RH, Conti DV, Langer-Gould AM (2012) Vitamin D levels in Hispanics with multiple sclerosis. J Neurol 259:2565–2570CrossRefPubMed Amezcua L, Chung RH, Conti DV, Langer-Gould AM (2012) Vitamin D levels in Hispanics with multiple sclerosis. J Neurol 259:2565–2570CrossRefPubMed
18.
Zurück zum Zitat Espinosa-Ramírez G, Ordoñez G, Flores-Rivera J, Sotelo J (2014) Sunlight exposure and multiple sclerosis in a tropical country. Neurol Res 36:647–650CrossRefPubMed Espinosa-Ramírez G, Ordoñez G, Flores-Rivera J, Sotelo J (2014) Sunlight exposure and multiple sclerosis in a tropical country. Neurol Res 36:647–650CrossRefPubMed
20.
Zurück zum Zitat Becker J, Callegaro D, Lana-Peixoto MA, Talim N, Vidaletti T, de Paula Corrêa M, Gomes I (2016) Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil. J Neurol Sci 363:236–239CrossRefPubMed Becker J, Callegaro D, Lana-Peixoto MA, Talim N, Vidaletti T, de Paula Corrêa M, Gomes I (2016) Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil. J Neurol Sci 363:236–239CrossRefPubMed
21.
Zurück zum Zitat Rito Y, Flores J, Fernández Aguilar Á, Escalante Membrillo C, Gutiérrez Lanz E, Barboza MA, Rivas Alonso V, Treviño Frenk I, Corona Vázquez T (2016) Vitamin D in multiple sclerosis patients: not the same risk for everybody. Mult Scler 22:126–127CrossRefPubMed Rito Y, Flores J, Fernández Aguilar Á, Escalante Membrillo C, Gutiérrez Lanz E, Barboza MA, Rivas Alonso V, Treviño Frenk I, Corona Vázquez T (2016) Vitamin D in multiple sclerosis patients: not the same risk for everybody. Mult Scler 22:126–127CrossRefPubMed
22.
Zurück zum Zitat Fragoso YD, Adoni T, Alves-Leon SV et al (2017) No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South. Arq Neuropsiquiatr 75:3–8CrossRefPubMed Fragoso YD, Adoni T, Alves-Leon SV et al (2017) No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South. Arq Neuropsiquiatr 75:3–8CrossRefPubMed
23.
Zurück zum Zitat Yildiz M, Tettenborn B, Putzki N (2011) Vitamin D levels in Swiss multiple sclerosis patients. Swiss Med Wkly 141:3–4 Yildiz M, Tettenborn B, Putzki N (2011) Vitamin D levels in Swiss multiple sclerosis patients. Swiss Med Wkly 141:3–4
24.
Zurück zum Zitat Ebers GC, Sadovnick AD, Veith R, Munger KL, O’Reilly E, Ascherio A (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 63:939CrossRefPubMed Ebers GC, Sadovnick AD, Veith R, Munger KL, O’Reilly E, Ascherio A (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 63:939CrossRefPubMed
25.
Zurück zum Zitat Barnes, Bonham MP, Robson PJ, Strain JJ, Lowe-strong AS (2007) Assessment of 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D 3 concentrations in male and female multiple sclerosis patients and control volunteers. Mult scler J 13(5):670–673CrossRef Barnes, Bonham MP, Robson PJ, Strain JJ, Lowe-strong AS (2007) Assessment of 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D 3 concentrations in male and female multiple sclerosis patients and control volunteers. Mult scler J 13(5):670–673CrossRef
26.
Zurück zum Zitat Mei IAF, Ponsonby A-L, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254:581–590CrossRefPubMed Mei IAF, Ponsonby A-L, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, Butzkueven H, McMichael AJ (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol 254:581–590CrossRefPubMed
27.
Zurück zum Zitat Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman C, Lips P (2009) Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 15:9–15CrossRefPubMed Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman C, Lips P (2009) Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler 15:9–15CrossRefPubMed
28.
Zurück zum Zitat McDowell T-Y, Amr S, Culpepper WJ, Langenberg P, Royal W, Bever C, Bradham DD (2011) Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis. Neuroepidemiology 36:39–45CrossRefPubMed McDowell T-Y, Amr S, Culpepper WJ, Langenberg P, Royal W, Bever C, Bradham DD (2011) Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis. Neuroepidemiology 36:39–45CrossRefPubMed
29.
Zurück zum Zitat Lonergan R, Kinsella K, Fitzpatrick P et al (2011) Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 82:317–322CrossRefPubMed Lonergan R, Kinsella K, Fitzpatrick P et al (2011) Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype. J Neurol Neurosurg Psychiatry 82:317–322CrossRefPubMed
30.
Zurück zum Zitat Runia TF, Hop WCJ, de Rijke YB, Buljevac D, Hintzen RQ (2012) Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 79:261–266CrossRefPubMed Runia TF, Hop WCJ, de Rijke YB, Buljevac D, Hintzen RQ (2012) Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 79:261–266CrossRefPubMed
31.
Zurück zum Zitat Saltytė Benth J, Myhr K-M, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T (2012) Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients. Neuroepidemiology 39:84–93CrossRefPubMed Saltytė Benth J, Myhr K-M, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T (2012) Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients. Neuroepidemiology 39:84–93CrossRefPubMed
32.
Zurück zum Zitat Thouvenot E, Orsini M, Daures J-P, Camu W (2015) Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis. Eur J Neurol 22:564–569CrossRefPubMed Thouvenot E, Orsini M, Daures J-P, Camu W (2015) Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis. Eur J Neurol 22:564–569CrossRefPubMed
33.
Zurück zum Zitat Du Y, Li JJ, Zhang YJ, Li K, He JF (2014) Risk factors for idiopathic optic neuritis recurrence. PLoS ONE 9:1–5 Du Y, Li JJ, Zhang YJ, Li K, He JF (2014) Risk factors for idiopathic optic neuritis recurrence. PLoS ONE 9:1–5
34.
Zurück zum Zitat Zhang Y, Liu G, Han X, Dong H, Geng J (2016) The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China. J Neuroimmunol 297:127–131CrossRefPubMed Zhang Y, Liu G, Han X, Dong H, Geng J (2016) The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China. J Neuroimmunol 297:127–131CrossRefPubMed
35.
Zurück zum Zitat Muris A-H, Smolders J, Rolf L, Klinkenberg LJJ, van der Linden N, Meex S, Damoiseaux J, Hupperts R (2016) Vitamin D status does not affect disability progression of patients with multiple sclerosis over three year follow-up. PLoS ONE 11:e0156122CrossRefPubMedPubMedCentral Muris A-H, Smolders J, Rolf L, Klinkenberg LJJ, van der Linden N, Meex S, Damoiseaux J, Hupperts R (2016) Vitamin D status does not affect disability progression of patients with multiple sclerosis over three year follow-up. PLoS ONE 11:e0156122CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Hatamian H, Bidabadi E, Mohammad S, Saadat S, Saadat NS, Kazemnezhad E, Ramezani H, Bakhshayesh B (2013) Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis? Iran J Neurol 12:41–46PubMedPubMedCentral Hatamian H, Bidabadi E, Mohammad S, Saadat S, Saadat NS, Kazemnezhad E, Ramezani H, Bakhshayesh B (2013) Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis? Iran J Neurol 12:41–46PubMedPubMedCentral
37.
Zurück zum Zitat Nikanfar M, Taheri-Aghdam AA, Yazdani M, Shaafi S, Masoudian N, Akbari H, Youhanaee P, Abbaszadeh H (2015) Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: a case-control study. Iran J Neurol 14:17–21PubMedPubMedCentral Nikanfar M, Taheri-Aghdam AA, Yazdani M, Shaafi S, Masoudian N, Akbari H, Youhanaee P, Abbaszadeh H (2015) Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: a case-control study. Iran J Neurol 14:17–21PubMedPubMedCentral
38.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRefPubMedPubMedCentral Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452CrossRefPubMed Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452CrossRefPubMed
41.
Zurück zum Zitat Cendrowski WS (1986) Progression index and disability status in multiple sclerosis: a resurvey of 207 patients in central Poland. Schweiz Arch Neurol Psychiatr 137:5–13PubMed Cendrowski WS (1986) Progression index and disability status in multiple sclerosis: a resurvey of 207 patients in central Poland. Schweiz Arch Neurol Psychiatr 137:5–13PubMed
42.
Zurück zum Zitat Lavery AM, Verhey LH, Waldman AT, Lavery AM, Verhey LH, Waldman AT (2014) Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials. Mult Scler Int 2014:262350PubMedPubMedCentral Lavery AM, Verhey LH, Waldman AT, Lavery AM, Verhey LH, Waldman AT (2014) Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials. Mult Scler Int 2014:262350PubMedPubMedCentral
43.
Zurück zum Zitat Abbott Diagnostics. Architect 25-OH Vitamin D Instructions for Use Abbott Laboratories, Abbott Park, IL (2011) Abbott Diagnostics. Architect 25-OH Vitamin D Instructions for Use Abbott Laboratories, Abbott Park, IL (2011)
45.
Zurück zum Zitat Tizaoui K, Kaabachi W, Hamzaoui A, Hamzaoui K (2015) Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cell Mol Immunol 12:243–252CrossRefPubMed Tizaoui K, Kaabachi W, Hamzaoui A, Hamzaoui K (2015) Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cell Mol Immunol 12:243–252CrossRefPubMed
Metadaten
Titel
Vitamin D and disability in relapsing–remitting multiple sclerosis in patients with a Mexican background
verfasst von
Yamel Rito
Jesus Flores
Angeles Fernández-Aguilar
Carmen Escalante-Membrillo
Miguel A. Barboza
Lilyana Amezcua
Teresa Corona
Publikationsdatum
03.10.2017
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 1/2018
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-017-0834-3

Weitere Artikel der Ausgabe 1/2018

Acta Neurologica Belgica 1/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.